Everly Health

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Everly Health sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials none currently recruiting 2 completed upper half by trial count

Everly Health: 2 sponsored US clinical trials, none currently recruiting.

Everly Health sponsors 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. The most-studied condition in this pipeline is SARS-CoV-2 Acute Respiratory Disease, with 1 trials.

Mid-pack sponsor footprint

Everly Health is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

How the Everly Health archive is shaped

2 indexed studies, none listed as recruiting (0% open); 2 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: SARS-CoV-2 Acute Respiratory Disease (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Everly Health: archived-pipeline peers nationwide

Peers matched on 2 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Everly Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Everly Health1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Everly Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Everly Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Everly Health page

2 registered trials is a research-attention snapshot, not an endorsement of Everly Health or any single study.

  • None of Everly Health's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • SARS-CoV-2 Acute Respiratory Disease is the condition Everly Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See SARS-CoV-2 Acute Respiratory Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Everly Health pipeline card: 2 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.